Table 4

Frequency of positive clinical and laboratory findings in suspected patients (n=130)

StagesDetected patients (%)RT-PCR (n=30)
Stage 154 (40.9%)17 (56.7%)
 1. Decrease in LOC24 (18.2)7 (23.3%)
 2. Unstable hemodynamics32 (24.2)9 (30%)
 3. Life-saving surgery5 (3.8%)1 (3.3%)
 4. Both 1 and 25 (3.8%)3 (10%)
 5. Both 1 and 32 (1.5%)1 (3.3%)
Stage 240 (30.3%)9 (30%)
 1. History of respiratory symptoms25 (18.9%)
 2. Epidemiological factors9 (6.8%)
 3. Fever20 (15.2%)
 4. RR >2021 (15.9)
 5. Sat O251 (38.6%)
Stage 314 (10.6%)0 (0%)
 1. Leukocytosis23 (17.4%)
 2. Lymphopenia27 (20.5%)
 3. High ESR13 (9.8%)
 4. High CRP23 (17.4%)
Stage 422 (16.7%)2 (6.7%)
 1. Fever2 (1.5%)2 (6.7%)
  • CRP, C-reactive peptide; ESR, erythrocyte sedimentation rate; LOC, level of consciousness; RR, respiratory rate; RT-PCR, reverse transcription-polymerase chain reaction.